Patrick Wood
Stock Analyst at Morgan Stanley
(3.05)
# 1,207
Out of 4,842 analysts
89
Total ratings
42.42%
Success rate
2.59%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Maintains: Equal-Weight | $240 → $260 | $245.00 | +6.12% | 4 | May 19, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $120 → $125 | $104.51 | +19.61% | 6 | May 16, 2025 | |
| GKOS Glaukos | Maintains: Underweight | $110 → $72 | $94.96 | -24.18% | 4 | May 6, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $86 → $78 | $71.15 | +9.63% | 6 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $280 → $196 | $173.01 | +13.29% | 4 | May 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $12 | $11.46 | +4.71% | 7 | May 6, 2025 | |
| TFX Teleflex | Maintains: Overweight | $191 → $173 | $121.09 | +42.87% | 5 | May 5, 2025 | |
| BAX Baxter International | Maintains: Underweight | $30 → $28 | $30.58 | -8.44% | 4 | May 5, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $80 | $72.63 | +10.15% | 4 | Mar 5, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Equal-Weight | $45 → $22 | $21.15 | +4.02% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $105 → $95 | $58.64 | +62.01% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $82 | $86.98 | -5.73% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $75 | $76.66 | -2.17% | 8 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $80.12 | +27.31% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $323.33 | -1.96% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $7.78 | +28.53% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $145 | $128.62 | +12.74% | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $65 → $85 | $85.38 | -0.45% | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $18.08 | +104.65% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $36 | $16.10 | +123.60% | 1 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $136.66 | - | 5 | Dec 11, 2017 |
STERIS
May 19, 2025
Maintains: Equal-Weight
Price Target: $240 → $260
Current: $245.00
Upside: +6.12%
Boston Scientific
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $104.51
Upside: +19.61%
Glaukos
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $94.96
Upside: -24.18%
GE HealthCare Technologies
May 6, 2025
Maintains: Equal-Weight
Price Target: $86 → $78
Current: $71.15
Upside: +9.63%
Becton, Dickinson and Company
May 6, 2025
Maintains: Overweight
Price Target: $280 → $196
Current: $173.01
Upside: +13.29%
Bausch + Lomb
May 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $12
Current: $11.46
Upside: +4.71%
Teleflex
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $121.09
Upside: +42.87%
Baxter International
May 5, 2025
Maintains: Underweight
Price Target: $30 → $28
Current: $30.58
Upside: -8.44%
Solventum
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $73 → $80
Current: $72.63
Upside: +10.15%
Tandem Diabetes Care
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $21.15
Upside: +4.02%
Feb 26, 2025
Maintains: Overweight
Price Target: $105 → $95
Current: $58.64
Upside: +62.01%
Feb 14, 2025
Maintains: Equal-Weight
Price Target: $75 → $82
Current: $86.98
Upside: -5.73%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $70 → $75
Current: $76.66
Upside: -2.17%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $80.12
Upside: +27.31%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $323.33
Upside: -1.96%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $7.78
Upside: +28.53%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $104 → $145
Current: $128.62
Upside: +12.74%
Jul 15, 2024
Upgrades: Equal-Weight
Price Target: $65 → $85
Current: $85.38
Upside: -0.45%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $18.08
Upside: +104.65%
Dec 4, 2023
Initiates: Overweight
Price Target: $36
Current: $16.10
Upside: +123.60%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $136.66
Upside: -